Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes - The strong heart study

被引:98
作者
Okin, PM
Devereux, RB
Lee, ET
Galloway, JM
Howard, BV
机构
[1] Cornell Med Ctr, Dept Med, Div Cardiol, New York, NY USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA
[3] Univ Arizona, Tucson, AZ USA
[4] Med Res Inst, Washington, DC USA
关键词
D O I
10.2337/diabetes.53.2.434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes is associated with increased risk of cardiovascular (CV) and all-cause mortality. Although electrocardiographic measures of repolarization abnormality and complexity stratify risk in the general population, their prognostic value in diabetes has not been well characterized. Digital electrocardiogram (ECG) readings were acquired for 994 American Indians with type 2 diabetes. ST segment depression (STD) greater than or equal to50 muV and rate-corrected QT interval (QTc) >460 ms were examined as measures of repolarization abnormality. The principal component analysis (PCA) of the ratio of the second to first eigenvalues of the T-wave vector (PCA ratio) ( > 32.0% in women and > 24.6% in men) was examined as a measure of repolarization complexity on the ECG. After a mean follow-up of 4.7 +/- 1.0 years, there were 56 CV deaths and 155 deaths from all causes. In univariate analyses, STD, QTc, and the PCA ratio predicted CV and all-cause mortality. After multivariate adjustment for age, sex, and other risk factors, STD (hazard ratio 3.68, 95% CI 1.70-7.96) and PCA ratio (2.61, 1.33-5.13) remained predictive of CV mortality and both STD (2.36, 1.38-4.02) and QTc (2.03, 1.32-3.12) predicted all-cause mortality. Computerized ECG measures of repolarization abnormality and complexity predict CV and all-cause mortality in type 2 diabetes, supporting their use to identify high-risk individuals with diabetes. Diabetes 53:434-440, 2004.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 40 条
[1]   HETEROGENEITY WITHIN THE VENTRICULAR WALL - ELECTROPHYSIOLOGY AND PHARMACOLOGY OF EPICARDIAL, ENDOCARDIAL, AND M-CELLS [J].
ANTZELEVITCH, C ;
SICOURI, S ;
LITOVSKY, SH ;
LUKAS, A ;
KRISHNAN, SC ;
DIDIEGO, JM ;
GINTANT, GA ;
LIU, DW .
CIRCULATION RESEARCH, 1991, 69 (06) :1427-1449
[2]  
Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
[3]   QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes [J].
Christensen, PK ;
Gall, MA ;
Major-Pedersen, A ;
Sato, A ;
Rossing, P ;
Breum, L ;
Pietersen, A ;
Kastrup, J ;
Parving, HH .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2000, 60 (04) :323-332
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   Association of nonspecific minor ST-T abnormalities with cardiovascular mortality - The Chicago Western Electric study [J].
Daviglus, ML ;
Liao, YL ;
Greenland, P ;
Dyer, AR ;
Liu, K ;
Xie, XY ;
Huang, CF ;
Prineas, RJ ;
Stamler, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (06) :530-536
[6]  
de Bruyne MC, 1998, CIRCULATION, V97, P467
[7]   THE PREDICTIVE VALUE OF ELECTROCARDIOGRAPHIC ABNORMALITIES FOR TOTAL AND CARDIOVASCULAR-DISEASE MORTALITY IN MEN AND WOMEN [J].
DEBACQUER, D ;
PEREIRA, LSM ;
DEBACKER, G ;
DE HENAUW, S ;
KORNITZER, M .
EUROPEAN HEART JOURNAL, 1994, 15 (12) :1604-1610
[8]   Impact of diabetes on cardiac structure and function - The strong heart study [J].
Devereux, RB ;
Roman, MJ ;
Paranicas, M ;
O'Grady, MJ ;
Lee, ET ;
Welty, TK ;
Fabsitz, RR ;
Robbins, D ;
Rhoades, ER ;
Howard, BV .
CIRCULATION, 2000, 101 (19) :2271-2276
[9]   MORBIDITY AND MORTALITY IN DIABETICS IN FRAMINGHAM POPULATION - 16-YEAR FOLLOW-UP STUDY [J].
GARCIA, MJ ;
MCNAMARA, PM ;
GORDON, T ;
KANNELL, WB .
DIABETES, 1974, 23 (02) :105-111
[10]   DURATION OF THE QT INTERVAL AND TOTAL AND CARDIOVASCULAR MORTALITY IN HEALTHY-PERSONS (THE FRAMINGHAM HEART-STUDY EXPERIENCE) [J].
GOLDBERG, RJ ;
BENGTSON, J ;
CHEN, Z ;
ANDERSON, KM ;
LOCATI, E ;
LEVY, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (01) :55-58